Dominican Republic

Dominican Republic

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.65 (0.56 - 0.75) 2019 Modelled IHME
0.67 (0.57 - 0.77) 2018 Modelled IHME
0.68 (0.58 - 0.79) 2017 Modelled IHME
0.7 (0.60 - 0.79) 2016 Modelled IHME
0.71 (0.61 - 0.80) 2015 Modelled IHME
0.72 (0.62 - 0.81) 2014 Modelled IHME
0.73 (0.62 - 0.83) 2013 Modelled IHME
0.74 (0.63 - 0.84) 2012 Modelled IHME
0.76 (0.63 - 0.87) 2011 Modelled IHME
0.77 (0.64 - 0.90) 2010 Modelled IHME
0.79 (0.66 - 0.91) 2009 Modelled IHME
0.81 (0.67 - 0.93) 2008 Modelled IHME
0.83 (0.70 - 0.95) 2007 Modelled IHME
0.85 (0.72 - 0.98) 2006 Modelled IHME
0.86 (0.72 - 0.99) 2005 Modelled IHME
0.88 (0.73 - 1.01) 2004 Modelled IHME
0.89 (0.73 - 1.03) 2003 Modelled IHME
0.9 (0.73 - 1.05) 2002 Modelled IHME
0.91 (0.73 - 1.07) 2001 Modelled IHME
0.92 (0.74 - 1.09) 2000 Modelled IHME
0.93 (0.74 - 1.09) 1999 Modelled IHME
0.94 (0.76 - 1.10) 1998 Modelled IHME
0.95 (0.77 - 1.11) 1997 Modelled IHME
0.96 (0.79 - 1.12) 1996 Modelled IHME
0.97 (0.79 - 1.13) 1995 Modelled IHME
0.97 (0.80 - 1.13) 1994 Modelled IHME
0.98 (0.80 - 1.14) 1993 Modelled IHME
0.98 (0.79 - 1.14) 1992 Modelled IHME
0.98 (0.79 - 1.15) 1991 Modelled IHME
0.98 (0.79 - 1.16) 1990 Modelled IHME
1.47 (0.11 - 13.35) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.18 (0.13 - 0.22) 2019 Modelled IHME
0.19 (0.13 - 0.24) 2018 Modelled IHME
0.2 (0.14 - 0.26) 2017 Modelled IHME
0.21 (0.15 - 0.27) 2016 Modelled IHME
0.22 (0.16 - 0.29) 2015 Modelled IHME
0.23 (0.17 - 0.29) 2014 Modelled IHME
0.23 (0.17 - 0.29) 2013 Modelled IHME
0.23 (0.17 - 0.30) 2012 Modelled IHME
0.23 (0.17 - 0.30) 2011 Modelled IHME
0.23 (0.17 - 0.30) 2010 Modelled IHME
0.23 (0.17 - 0.30) 2009 Modelled IHME
0.23 (0.17 - 0.29) 2008 Modelled IHME
0.22 (0.16 - 0.28) 2007 Modelled IHME
0.21 (0.16 - 0.27) 2006 Modelled IHME
0.21 (0.16 - 0.27) 2005 Modelled IHME
0.22 (0.17 - 0.28) 2004 Modelled IHME
0.25 (0.18 - 0.32) 2003 Modelled IHME
0.29 (0.20 - 0.37) 2002 Modelled IHME
0.32 (0.23 - 0.42) 2001 Modelled IHME
0.35 (0.24 - 0.47) 2000 Modelled IHME
0.37 (0.26 - 0.48) 1999 Modelled IHME
0.39 (0.28 - 0.50) 1998 Modelled IHME
0.41 (0.30 - 0.52) 1997 Modelled IHME
0.43 (0.32 - 0.56) 1996 Modelled IHME
0.45 (0.33 - 0.60) 1995 Modelled IHME
0.48 (0.36 - 0.62) 1994 Modelled IHME
0.51 (0.38 - 0.66) 1993 Modelled IHME
0.55 (0.41 - 0.71) 1992 Modelled IHME
0.59 (0.43 - 0.77) 1991 Modelled IHME
0.64 (0.45 - 0.84) 1990 Modelled IHME
0.34 (0.03 - 3.33) 2015 Modelled WHO
Showing out of
Show more

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
27 (20 - 36) 2019 Modelled IHME
28 (21 - 36) 2018 Modelled IHME
28 (21 - 36) 2017 Modelled IHME
28 (21 - 36) 2016 Modelled IHME
27 (20 - 36) 2015 Modelled IHME
27 (20 - 36) 2014 Modelled IHME
27 (21 - 36) 2013 Modelled IHME
27 (21 - 35) 2012 Modelled IHME
27 (21 - 35) 2011 Modelled IHME
27 (21 - 35) 2010 Modelled IHME
27 (21 - 35) 2009 Modelled IHME
28 (21 - 35) 2008 Modelled IHME
28 (21 - 35) 2007 Modelled IHME
28 (21 - 35) 2006 Modelled IHME
28 (21 - 35) 2005 Modelled IHME
28 (22 - 36) 2004 Modelled IHME
28 (22 - 36) 2003 Modelled IHME
28 (22 - 36) 2002 Modelled IHME
29 (22 - 37) 2001 Modelled IHME
29 (22 - 37) 2000 Modelled IHME
29 (23 - 37) 1999 Modelled IHME
30 (23 - 38) 1998 Modelled IHME
30 (23 - 38) 1997 Modelled IHME
30 (23 - 38) 1996 Modelled IHME
30 (23 - 38) 1995 Modelled IHME
30 (23 - 38) 1994 Modelled IHME
30 (24 - 39) 1993 Modelled IHME
31 (24 - 39) 1992 Modelled IHME
31 (24 - 39) 1991 Modelled IHME
31 (24 - 39) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
65 2018 Survey/reported WHO/UNICEF
67 2017 Survey/reported WHO/UNICEF
66 2016 Survey/reported WHO/UNICEF
64 2015 Survey/reported WHO/UNICEF
67 2014 Survey/reported WHO/UNICEF
63 2013 Survey/reported WHO/UNICEF
59 2012 Survey/reported WHO/UNICEF
67 2011 Survey/reported WHO/UNICEF
65 2010 Survey/reported WHO/UNICEF
58 2009 Survey/reported WHO/UNICEF
54 2008 Survey/reported WHO/UNICEF
46 2007 Survey/reported WHO/UNICEF
75 2006 Survey/reported WHO/UNICEF
75 2005 Survey/reported WHO/UNICEF
66 2004 Survey/reported WHO/UNICEF
66 2003 Survey/reported WHO/UNICEF
66 2002 Survey/reported WHO/UNICEF
66 2001 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
92 2018 Survey/reported WHO/UNICEF
81 2017 Survey/reported WHO/UNICEF
80 2016 Survey/reported WHO/UNICEF
81 2015 Survey/reported WHO/UNICEF
89 2014 Survey/reported WHO/UNICEF
80 2013 Survey/reported WHO/UNICEF
74 2012 Survey/reported WHO/UNICEF
80 2011 Survey/reported WHO/UNICEF
83 2010 Survey/reported WHO/UNICEF
80 2009 Survey/reported WHO/UNICEF
81 2008 Survey/reported WHO/UNICEF
81 2007 Survey/reported WHO/UNICEF
84 2006 Survey/reported WHO/UNICEF
87 2005 Survey/reported WHO/UNICEF
82 2004 Survey/reported WHO/UNICEF
79 2003 Survey/reported WHO/UNICEF
63 2002 Survey/reported WHO/UNICEF
66 2001 Survey/reported WHO/UNICEF
68 2000 Survey/reported WHO/UNICEF
76 1999 Survey/reported WHO/UNICEF
62 1998 Survey/reported WHO/UNICEF
Showing out of
Show more
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
1997
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.92 (1.56 - 2.37) 2019 Modelled IHME
1.91 (1.54 - 2.37) 2018 Modelled IHME
1.9 (1.52 - 2.35) 2017 Modelled IHME
1.87 (1.51 - 2.31) 2016 Modelled IHME
1.84 (1.49 - 2.28) 2015 Modelled IHME
1.81 (1.46 - 2.24) 2014 Modelled IHME
1.77 (1.44 - 2.19) 2013 Modelled IHME
1.74 (1.42 - 2.15) 2012 Modelled IHME
1.72 (1.39 - 2.12) 2011 Modelled IHME
1.71 (1.38 - 2.11) 2010 Modelled IHME
1.71 (1.38 - 2.11) 2009 Modelled IHME
1.71 (1.39 - 2.11) 2008 Modelled IHME
1.71 (1.39 - 2.11) 2007 Modelled IHME
1.72 (1.39 - 2.13) 2006 Modelled IHME
1.72 (1.40 - 2.13) 2005 Modelled IHME
1.73 (1.40 - 2.15) 2004 Modelled IHME
1.75 (1.41 - 2.18) 2003 Modelled IHME
1.77 (1.42 - 2.20) 2002 Modelled IHME
1.79 (1.43 - 2.23) 2001 Modelled IHME
1.8 (1.43 - 2.25) 2000 Modelled IHME
1.79 (1.43 - 2.23) 1999 Modelled IHME
1.78 (1.43 - 2.21) 1998 Modelled IHME
1.77 (1.43 - 2.18) 1997 Modelled IHME
1.75 (1.42 - 2.15) 1996 Modelled IHME
1.74 (1.41 - 2.13) 1995 Modelled IHME
1.72 (1.40 - 2.10) 1994 Modelled IHME
1.71 (1.39 - 2.07) 1993 Modelled IHME
1.69 (1.38 - 2.06) 1992 Modelled IHME
1.67 (1.36 - 2.04) 1991 Modelled IHME
1.65 (1.33 - 2.03) 1990 Modelled IHME
Showing out of
Show more

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
22 (15 - 29) 2019 Modelled IHME
22 (15 - 29) 2018 Modelled IHME
22 (15 - 29) 2017 Modelled IHME
22 (15 - 29) 2016 Modelled IHME
22 (15 - 29) 2015 Modelled IHME
22 (16 - 29) 2014 Modelled IHME
22 (16 - 29) 2013 Modelled IHME
22 (16 - 29) 2012 Modelled IHME
23 (16 - 29) 2011 Modelled IHME
23 (16 - 30) 2010 Modelled IHME
23 (16 - 29) 2009 Modelled IHME
22 (16 - 29) 2008 Modelled IHME
22 (16 - 29) 2007 Modelled IHME
22 (16 - 29) 2006 Modelled IHME
22 (16 - 29) 2005 Modelled IHME
22 (16 - 29) 2004 Modelled IHME
22 (16 - 29) 2003 Modelled IHME
22 (16 - 29) 2002 Modelled IHME
22 (16 - 29) 2001 Modelled IHME
22 (15 - 29) 2000 Modelled IHME
21 (15 - 28) 1999 Modelled IHME
21 (15 - 28) 1998 Modelled IHME
21 (15 - 28) 1997 Modelled IHME
21 (15 - 28) 1996 Modelled IHME
21 (15 - 28) 1995 Modelled IHME
21 (15 - 27) 1994 Modelled IHME
21 (15 - 28) 1993 Modelled IHME
21 (15 - 27) 1992 Modelled IHME
21 (15 - 27) 1991 Modelled IHME
21 (15 - 27) 1990 Modelled IHME
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
1997
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
0.65 (%)
2019
(0.56 - 0.75(%))
IHME
HCV (RNA/cAg+)
1.92 (%)
2019
(1.56 - 2.37(%))
IHME

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
361
2019
(242 - 516)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
661
2019
(433 - 956)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.18 (%)
2019, latest modelled
(0.13 - 0.22(%))
IHME

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
65 (%)
2018
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines